PAVmed Inc (STU:1P50)
€ 2.78999 0 (0%) Market Cap: 10.40 Mil Enterprise Value: 36.24 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 37/100

Q4 2020 PAVmed Inc Earnings Call Transcript

Feb 22, 2021 / 01:30PM GMT
Release Date Price: €42.23 (-11.58%)
Operator

Greetings, and welcome to PAVmed Inc. Business Update Conference call. (Operator Instructions) As a reminder, this conference is being recorded.

I would now like to turn this conference over to your host, Mr. Mike Havrilla, Director of Investor Relations for PAVmed. Please go ahead, sir.

Mike Havrilla

Thanks, operator. Good morning, everyone. This is Mike Havrilla, PAVmed's Director of Investor Relations. Thanks for participating in today's business update call.

Joining me today on the call are Dr. Lishan Aklog, Chairman and Chief Executive Officer; Dennis McGrath, President and Chief Financial Officer, and we are pleased to have a guest speaker joining us today, Stanley Lapidus, Strategic Adviser from Lucid Diagnostics.

The press release announcing our business update results is available on PAVmed's website. If you could take a moment to read the disclaimer about forward-looking statements in the press release. The business update press release and this teleconference both include forward-looking statements. These forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot